Skip to content

Clinical trials

Recruiting Prostatic Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Status: Recruiting Country / region: Germany Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20161
20182
20192
20202
20211
20223
20234
202413
202514
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting51

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Novartis Pharmaceuticals4
Amgen3
Heinrich-Heine University, Duesseldorf3
University Hospital Tuebingen3
Martini-Klinik am UKE GmbH2
Merck Sharp & Dohme LLC2
University of Erlangen-Nürnberg Medical School2
ABX advanced biochemical compounds GmbH1
Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms51
Breast Neoplasms9
Head and Neck Neoplasms6
Esophageal Neoplasms5
Adenocarcinoma4
Neoplasms4
Colorectal Neoplasms3
Endometrial Neoplasms3
Lung Neoplasms3
Neoplasm Metastasis3

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.